References
- Carlsson J, Nordgren H, Sjöström J et al. HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. Br J Cancer. 2004 Jun 14;90(12):2344–8.
- Caturegli P, Di Dalmazi G, Lombardi M et al. Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series. Am J Pathol. 2016 Dec;186(12):3225–3235.
- Chung TT, Monson JP. Hypopituitarism. [Updated 2022 Nov 27]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278989/.
- Copeland-Halperin RS, Liu JE, Yu AF. Cardiotoxicity of HER2-targeted therapies. Curr Opin Cardiol. 2019 Jul;34(4):451–458.
- Fassett DR, Couldwell WT. Metastases to the pituitary gland. Neurosurg Focus. 2004 Apr 15;16(4):E8.
- Fleseriu M, Hashim IA, Karavitaki N et al. Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016 Nov;101(11):3888–3921.
- Foppiani L, Ruelle A, Bandelloni R et al. Hypopituitarism in the elderly: multifaceted clinical and biochemical presentation. Curr Aging Sci. 2008 Mar;1(1):42–50.
- Fortunati N, Felicetti F, Donadio M et al. Pituitary lesions in breast cancer patients: A report of three cases. Oncol Lett. 2015 Jun;9(6):2762–2766.
- Gounden V, Anastasopoulou C, Jialal I. Hypopituitarism. [Updated 2023 Sep 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470414/.
- Gunawardena V, Candelario-Cosme M, Lilienfield H. A case of anterior hypopituitarism as the initial presentation in pituitary metastasis from breast cancer. Presented at Society for Endocrinology BES 201, Brighton, UK. Endocrine Abstracts (2016) 44 EP64.
- Guy RL, Benn JJ, Ayers AB et al. A comparison of CT and MRI in the assessment of the pituitary and parasellar region. Clin Radiol. 1991 Mar;43(3):156–61.
- Higham CE, Johannsson G, Shalet SM. Hypopituitarism. Lancet. 2016 Nov 12;388(10058):2403–2415.
- Iwama S, De Remigis A, Callahan MK et al. Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody. Sci Transl Med. 2014 Apr 2;6(230):230ra45.
- Johnstone C, Hendry C, Farley A et al. Endocrine system: part 1. Nurs Stand. 2014 May 27;28(38):42–9.
- Kim SY. Diagnosis and Treatment of Hypopituitarism. Endocrinol Metab (Seoul). 2015 Dec;30(4):443–55.
- Oueslati I, Ayari S, Yazidi M et al. Hypopituitarism secondary to a pituitary metastasis in a young woman with an invasive breast carcinoma. Clin Case Rep. 2021 May 5;9(6):e04175.
- Pekic S, Popovic V. DIAGNOSIS OF ENDOCRINE DISEASE: Expanding the cause of hypopituitarism. Eur J Endocrinol. 2017 Jun;176(6):R269-R282.
- Petiti JP, Sosa LDV, Picech F et al. Trastuzumab inhibits pituitary tumor cell growth modulating the TGFB/SMAD2/3 pathway. Endocr Relat Cancer. 2018 Oct;25(10):837–852.
- Sturm I, Kirschke S, Krahl D, Dörken B. Panhypopituitarism in a patient with breast cancer. Onkologie. 2004 Oct;27(5):480–2.
- Varrassi M, Cobianchi Bellisari F, Bruno F et al. High-resolution magnetic resonance imaging at 3T of pituitary gland: advantages and pitfalls. Gland Surg. 2019 Sep;8(Suppl 3):S208-S215.